KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes... << Prices as on May 12, 2025 >>  ABB India 5586.2  [ 2.62% ]  ACC 1859.1  [ 2.53% ]  Ambuja Cements 541.45  [ 2.57% ]  Asian Paints Ltd. 2354.1  [ 2.34% ]  Axis Bank Ltd. 1204.1  [ 4.40% ]  Bajaj Auto 8038.9  [ 4.63% ]  Bank of Baroda 226.85  [ 3.04% ]  Bharti Airtel 1872.2  [ 1.30% ]  Bharat Heavy Ele 232.95  [ 7.47% ]  Bharat Petroleum 308.9  [ 0.72% ]  Britannia Ind. 5608.7  [ 3.39% ]  Cipla 1512  [ 2.27% ]  Coal India 395.45  [ 3.35% ]  Colgate Palm. 2610.75  [ 2.34% ]  Dabur India 475.3  [ 2.69% ]  DLF Ltd. 680.75  [ 7.80% ]  Dr. Reddy's Labs 1195.35  [ 3.37% ]  GAIL (India) 187.8  [ 3.36% ]  Grasim Inds. 2739.4  [ 4.02% ]  HCL Technologies 1669.65  [ 6.35% ]  HDFC Bank 1957.55  [ 3.62% ]  Hero MotoCorp 3990.55  [ 3.54% ]  Hindustan Unilever L 2382.95  [ 2.10% ]  Hindalco Indus. 651.85  [ 3.91% ]  ICICI Bank 1449.7  [ 4.39% ]  Indian Hotels Co 769.35  [ 6.94% ]  IndusInd Bank 788.65  [ -3.57% ]  Infosys L 1626.7  [ 7.91% ]  ITC Ltd. 435.5  [ 2.83% ]  Jindal St & Pwr 904.85  [ 5.73% ]  Kotak Mahindra Bank 2146.05  [ 2.01% ]  L&T 3586.6  [ 4.09% ]  Lupin Ltd. 2040.95  [ 0.15% ]  Mahi. & Mahi 3104.5  [ 4.08% ]  Maruti Suzuki India 12615.4  [ 2.96% ]  MTNL 41.4  [ 5.69% ]  Nestle India 2382.45  [ 2.52% ]  NIIT Ltd. 136.5  [ 5.65% ]  NMDC Ltd. 68.04  [ 5.72% ]  NTPC 348.7  [ 4.21% ]  ONGC 244  [ 3.94% ]  Punj. NationlBak 95.8  [ 4.19% ]  Power Grid Corpo 309.05  [ 3.17% ]  Reliance Inds. 1436.55  [ 4.27% ]  SBI 801.6  [ 2.85% ]  Vedanta 435.9  [ 6.88% ]  Shipping Corpn. 173.3  [ 6.98% ]  Sun Pharma. 1686.25  [ -3.36% ]  Tata Chemicals 848.25  [ 3.77% ]  Tata Consumer Produc 1144.9  [ 2.79% ]  Tata Motors 720.55  [ 1.70% ]  Tata Steel 151.55  [ 6.16% ]  Tata Power Co. 391.65  [ 5.52% ]  Tata Consultancy 3620.3  [ 5.17% ]  Tech Mahindra 1572.65  [ 5.34% ]  UltraTech Cement 11738.55  [ 3.21% ]  United Spirits 1563.8  [ 2.06% ]  Wipro 257.4  [ 6.41% ]  Zee Entertainment En 117.15  [ 1.12% ]  
  • Share Prices
  • Tools
  • News
  • Company Details
  • Financial Data
  • Results
  • Key Financial Ratios
  • Reports
  • Corporate Announcements
  • Equity History

    • Company Information

    Indian Indices
    • Loading....

    Global Indices
    • Loading....

    Forex
    • Loading....

    GLENMARK PHARMACEUTICALS LTD.

    12 May 2025 | 12:00

    Industry >> Pharmaceuticals

    Select Another Company

    ISIN No INE935A01035 BSE Code / NSE Code 532296 / GLENMARK Book Value (Rs.) 299.28 Face Value 1.00
    Bookclosure 27/09/2024 52Week High 1831 EPS 0.00 P/E 0.00
    Market Cap. 38991.69 Cr. 52Week Low 985 P/BV / Div Yield (%) 4.62 / 0.18 Market Lot 1.00
    Security Type Other
    • Select another Company

    Quarterly Trends

    Glenmark Pharmaceuticals Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202412(3) 202409(3) 202412(3) 202409(3)
    OprtIncome Glenmark Pharmaceuticals Ltd. 2251.28 2636.10 Aarey Drugs & Pharmaceuticals Ltd. 133.79 105.14
    OtherRecurrInc Glenmark Pharmaceuticals Ltd. 129.19 83.08 Aarey Drugs & Pharmaceuticals Ltd. 0.68 0.02
    Operating profit Glenmark Pharmaceuticals Ltd. 438.76 723.78 Aarey Drugs & Pharmaceuticals Ltd. 1.62 3.23
    GrossProfit Glenmark Pharmaceuticals Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    ReportedPAT Glenmark Pharmaceuticals Ltd. 413.80 595.06 Aarey Drugs & Pharmaceuticals Ltd. 0.72 1.60
    Equity Capital Glenmark Pharmaceuticals Ltd. 28.22 28.22 Aarey Drugs & Pharmaceuticals Ltd. 28.05 28.05
    OPM Glenmark Pharmaceuticals Ltd. 19.48 27.45 Aarey Drugs & Pharmaceuticals Ltd. 1.21 3.07
    GPM Glenmark Pharmaceuticals Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    NPM Glenmark Pharmaceuticals Ltd. 18.38 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.53 1.51

    Annual Trends

    Glenmark Pharmaceuticals Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202403(12) 202303(12) 202403(12) 202303(12)
    OperatingIncome Glenmark Pharmaceuticals Ltd. 7891.12 8220.66 Aarey Drugs & Pharmaceuticals Ltd. 395.62 418.96
    OperatingProfit Glenmark Pharmaceuticals Ltd. 1241.66 1472.77 Aarey Drugs & Pharmaceuticals Ltd. 4.45 7.72
    OtherRecurrInc Glenmark Pharmaceuticals Ltd. 1168.02 985.94 Aarey Drugs & Pharmaceuticals Ltd. 6.96 2.73
    AdjustedPBT Glenmark Pharmaceuticals Ltd. 1930.42 2067.74 Aarey Drugs & Pharmaceuticals Ltd. 5.34 6.01
    ReportedPAT Glenmark Pharmaceuticals Ltd. 5167.29 1208.77 Aarey Drugs & Pharmaceuticals Ltd. 4.68 3.77
    EquityDividend Glenmark Pharmaceuticals Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    EquityCapital Glenmark Pharmaceuticals Ltd. 28.22 28.22 Aarey Drugs & Pharmaceuticals Ltd. 28.05 25.38
    PreferenceCapital Glenmark Pharmaceuticals Ltd. 0.00 0.00 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00
    ResAndSurplus Glenmark Pharmaceuticals Ltd. 22939.88 17849.25 Aarey Drugs & Pharmaceuticals Ltd. 102.25 89.71
    LoanFunds Glenmark Pharmaceuticals Ltd. 657.24 3156.40 Aarey Drugs & Pharmaceuticals Ltd. 31.35 37.72
    AL_CurrentLiabilities Glenmark Pharmaceuticals Ltd. 3786.54 3552.06 Aarey Drugs & Pharmaceuticals Ltd. 139.17 136.20
    NetBlock Glenmark Pharmaceuticals Ltd. 1756.24 1745.94 Aarey Drugs & Pharmaceuticals Ltd. 12.96 13.94
    Investments Glenmark Pharmaceuticals Ltd. 12964.79 10334.01 Aarey Drugs & Pharmaceuticals Ltd. 1.38 0.40
    TotCurrentAssets Glenmark Pharmaceuticals Ltd. 12495.69 12333.63 Aarey Drugs & Pharmaceuticals Ltd. 288.95 276.99

    Ratios

    Glenmark Pharmaceuticals Ltd. Aarey Drugs & Pharmaceuticals Ltd.
    Year Ends (Months) 202403(12) 202303(12) 202403(12) 202303(12)
    OPM Glenmark Pharmaceuticals Ltd. 15.73 17.91 Aarey Drugs & Pharmaceuticals Ltd. 1.12 1.84
    NPM Glenmark Pharmaceuticals Ltd. 65.48 14.70 Aarey Drugs & Pharmaceuticals Ltd. 1.18 0.90
    Reported EPS Glenmark Pharmaceuticals Ltd. 183.13 42.84 Aarey Drugs & Pharmaceuticals Ltd. 1.67 1.49
    Return on Networth Glenmark Pharmaceuticals Ltd. 22.49 6.76 Aarey Drugs & Pharmaceuticals Ltd. 3.59 3.27
    Debt/ Equity Glenmark Pharmaceuticals Ltd. 0.02 0.17 Aarey Drugs & Pharmaceuticals Ltd. 0.24 0.32
    Financial Charges Coverage Ratio Glenmark Pharmaceuticals Ltd. 8.70 11.89 Aarey Drugs & Pharmaceuticals Ltd. 2.61 3.65
    Current Ratio Glenmark Pharmaceuticals Ltd. 3.30 3.47 Aarey Drugs & Pharmaceuticals Ltd. 2.08 2.03
    Dividend per share Glenmark Pharmaceuticals Ltd. 2.50 2.50 Aarey Drugs & Pharmaceuticals Ltd. 0.00 0.00

    Way2Wealth Brokers Private Limited - CIN U67120KA2000PTC027628 Stock Broking: SEBI Regn No.: INZ000178638 | Exchange Membership ID: NSE: 11502, BSE: 3117, MSEI:51000, MCX: 56730 Depository Participant: SEBI Regn No. IN-DP-472-2020 | CDSL ID: 12062900 & 12031500, NSDL ID: IN303077 PMS: SEBI Regn No.INP000000829 | Register with AMFI ARN: 77558 (Date of Initial registration - 8th Dec 2009, Date of expiry - 24th Jan 2027) | PFRDA: POP226012019

    Way2Wealth Commodities Private Limited - CIN U51229KA2006PTC039880 Stock Broking: SEBI Regn No.: INZ000049130 | Exchange Membership ID: NCDEX : 00908

    Copyrights @ 2014 © Way2Wealth Brokers Pvt. Ltd. All rights reserved

    Designed, developed and content provided by  Dion

    Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.